EGFR and lung adenocarcinoma: TR64 (stage IIIA, adenocarcinoma, 71-year-old male, non-smoker) has an EGFR missense mutation c.2573T>G characterized as pathogenic with moderate impact on protein function and reported in lung adenocarcinoma.